Jacques said “ADVI has a unique and deep expertise in translating its life science, service, digital health, and managed care client business imperatives into the language and framework of public and private payers.
Washington, DC (PRWEB) February 28, 2014
Prior to joining ADVI, Dr. Jacques served as Director of the Coverage and Analysis Group (CAG) within the Center for Clinical Standards and Quality (CCSQ) at the Centers for Medicare and Medicaid Services (CMS). Jacques will begin with ADVI on March 1, 2014.
During his 10 years as Director of CAG and its Division of Items and Devices, Jacques implemented Coverage with Evidence Development (CED) providing an innovative pathway to national coverage for certain services under the Medicare program. He also co-created the parallel review pilot between CMS and the Food and Drug Administration (FDA), was responsible for changes to Medicare coverage in FDA IDE trials, co-authored over 60 Medicare National Coverage Determinations (NCD) on topics such as molecular testing, implanted devices, preventive services and drugs and biologics, and developed program oversight of the Local Coverage Determination (LCD) process.
Prior to serving at CMS, Dr. Jacques practiced medicine as an attending physician for almost 20 years and was an Associate Dean at Georgetown University School of Medicine.
“Having Louis at ADVI enhances our already significant understanding of the people, processes, and politics underlying Medicare national and local coverage, the collaboration between FDA and CMS, and the partnership between private payers and government,” said Marc Samuels, ADVI CEO. “Given Louis’ unique experience collaborating with FDA from within CMS, he will effectively lead ADVI's clients through pre-launch clinical trial development and the measurement of clinical effectiveness and utility; he will enhance our work to guide clients through today's unprecedented transformation in health care delivery and financing as ‘pay for value constructs’ will require evidencing value and tying remuneration of our client's offerings to the evidencing of that value.”
Jacques said “ADVI has a unique and deep expertise in translating its life science, service, digital health, and managed care client business imperatives into the language and framework of public and private payers. I have known Marc Samuels and others on the ADVI team for over 10 years. They have been at the forefront of the most seminal coverage, payment, innovation and reform decisions or initiatives before CMS and its contractors. The firm’s advice is top notch and I look forward to working with my new colleagues to further guide ADVI clients through these transformational times.”
Dr. Jacques is a graduate of Georgetown University and The University of Maryland School of Medicine.
ADVI is unique; a partnership of government, scientific, industry, payer, and professional consultancy experience and expertise offering a rare combination of leadership experience, industry relationships, knowledge of political and policy processes, reimbursement background, and transactional expertise dedicated to advancing the business imperatives of our clients by meeting the challenges of the healthcare system as they exist today, and tomorrow. We deliver a balanced viewpoint, informed substance, and tested solutions to help our clients make winning strategic business, management and reimbursement decisions, conduct successful policy analysis and planning, and achieve results through advocacy and implementation.
The firm represents a sophisticated client base of Fortune 50 life sciences and health care services companies as well as innovative, venture and private equity backed companies in diagnostics, digital health, health information technology and health care services. Currently the firm is at the forefront of many health care delivery transformation, payment reform, and local and national public and private payer coverage and quality issues and in healthcare merger and acquisition deal flow.
For more information, visit http://www.advi.com.